Crossmark

Vilazodone, a Selective Serotonin Reuptake Inhibitor with Diminished Impact on Methylphenidate-Induced Gene Regulation in the Striatum: Role of 5-HT1A Receptor

Crossref DOI link: https://doi.org/10.1007/s12035-023-03688-y

Published Online: 2023-10-09

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hrabak, Michael

Moon, Connor

Bolaños-Guzmán, Carlos A.

Steiner, Heinz https://orcid.org/0000-0002-9139-1312
Funding

Funding for this research was provided by:

National Institute on Drug Abuse (DA046794)
License Information

Text and Data Mining valid from 2023-10-09

Version of Record valid from 2023-10-09
More Information

Article History

Received: 1 May 2023

Accepted: 1 October 2023

First Online: 9 October 2023

Declarations

:

: The authors have no conflicts of interest or relevant financial interests to declare.

: All experimental procedures met the National Institutes of Health (NIH) guidelines for the care and use of laboratory animals (National Research Council, 2003) and were approved by the Rosalind Franklin University Animal Care and Use Committee.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below